Inflammatory mechanisms: the molecular basis of inflammation and disease.
暂无分享,去创建一个
[1] U. Andersson,et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.
[2] P. Libby,et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[3] V. Pasceri,et al. A tale of two diseases: atherosclerosis and rheumatoid arthritis. , 1999, Circulation.
[4] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] F. Lowy,et al. Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression , 1995, Infection and immunity.
[6] A. Pearson. Scavenger receptors in innate immunity. , 1996, Current opinion in immunology.
[7] P. Libby,et al. CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1 , 2007, Circulation.
[8] P. Ridker. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. , 2007, Journal of the American College of Cardiology.
[9] Peter Libby,et al. Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.
[10] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[11] A. J. Valente,et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Wagner,et al. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes , 1989, Cell.
[13] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[14] Kathleen M. Smith,et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Phipps. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Libby,et al. Pathophysiology of Coronary Artery Disease , 2005, Circulation.
[17] P. Libby,et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.
[18] A. Tedgui,et al. Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability , 2001, Circulation.
[19] M. Arditi,et al. Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells , 2000, The Journal of Biological Chemistry.
[20] Ralph Weissleder,et al. Molecular and cellular imaging of atherosclerosis: emerging applications. , 2006, Journal of the American College of Cardiology.
[21] P. Libby,et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. , 2000, The American journal of pathology.
[22] Rodger P. McEver,et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140 , 1990, Nature.
[23] P. Libby,et al. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.
[24] M. Daemen,et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Libby,et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.
[26] V. Ord,et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.
[27] P. Libby,et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.
[28] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[29] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[30] Michael Ginsberg,et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Libby,et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[33] R D Kamm,et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. , 1992, Circulation research.
[34] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[35] S. Saccani,et al. The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.
[36] P. Libby,et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[37] M. Krieger,et al. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.
[38] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.
[39] N. Mackman,et al. LPS induction of gene expression in human monocytes. , 2001, Cellular signalling.
[40] Y. Yazaki,et al. Platelet-derived growth factor BB-dimer suppresses the expression of macrophage colony-stimulating factor in human vascular smooth muscle cells. , 1992, The Journal of biological chemistry.
[41] P. Libby,et al. Atherosclerosis: the path from genomics to therapeutics. , 2007, Journal of the American College of Cardiology.
[42] P. Libby,et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.
[43] D. Dowbenko,et al. Cloning of a lymphocyte homing receptor reveals a lectin domain , 1989, Cell.
[44] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[45] M. Krieger,et al. The other side of scavenger receptors: pattern recognition for host defense , 1997, Current opinion in lipidology.
[46] J Bajorath,et al. Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.
[47] J. Campbell,et al. ICAM-1 expression by vascular smooth muscle cells is phenotype-dependent. , 2000, Atherosclerosis.
[48] G. Hansson,et al. T Cells in Atherogenesis: For Better or For Worse? , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[49] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[50] G. V. R. Born,et al. INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.
[51] S. Wright. Toll, A New Piece in the Puzzle of Innate Immunity , 1999, The Journal of experimental medicine.
[52] B. Seed,et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.
[53] P. Libby. Inflammation in atherosclerosis , 2002, Nature.